The Food and Drug Administration Friday announced that it had approved Rapamune (sirolimus), distributed by Pfizer’s Wyeth Pharmaceuticals, as a treatment for the rare lung disease lymphangioleiomyomatosis (LAM).
As GMDC’s annual General Merchandise Conference gets underway in Orlando, Fla., spirits are running high as the association will unveil several new initiatives and will celebrate the appointment of Patrick Spear as the new CEO during the event.
Are you satisfied with your looks? According to new GfK research, 60% of people in the United States said they are “completely” or “fairly” satisfied with their looks — slightly higher than the global average of 55%.
Recognizing that onsite health facilities can be an integral component of a successful health care program, employers are seeking to expand their use of such centers in the coming years, according to new research by global professional services company Towers Watson.
The AARP Public Policy Institute’s latest Rx Price Watch Report shows that, despite an overall 4% decrease in price in 2013, the prices of generic drugs seem to be dropping at the slowest rate since 2006.